Cardiff Oncology, Inc.CRDFNASDAQ
Loading
P/E Ratio HistoryNormalizing
Percentile Rank57
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-4.09
Near historical average
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthNormalizing
Average
-4.25
Historical baseline
PeriodValueYoY Change
2025-4.09+10.1%
2024-4.55-185.3%
2023-1.60-1.2%
2022-1.58+81.0%
2021-8.29+57.4%
2020-19.45-4210.0%
2019-0.45-0.3%
2018-0.45-4.3%
2017-0.43+73.3%
2016-1.62-